7Baggers
 Esperion settles patent litigation with Dr. Reddy’s Laboratories  Investing.com Fri, 03 Oct 2025 12:52:09 GMT
 Esperion Reaches Settlement Agreement with ANDA Filer, Dr.  GlobeNewswire Fri, 03 Oct 2025 12:01:35 GMT
 Esperion’s Stock Surge: Analyzing Market Moves  StocksToTrade Wed, 01 Oct 2025 18:05:00 GMT
 esperion therapeutics (nasdaq:espr) trading up 6.7% - what's next?  MarketBeat Thu, 25 Sep 2025 19:31:16 GMT
 esperion therapeutics (nasdaq:espr) cfo sells $19,799.26 in stock  MarketBeat Mon, 22 Sep 2025 02:47:55 GMT
 esperion therapeutics (nasdaq:espr) cfo sells $19,799.26 in stock  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 esperion therapeutics (nasdaq:espr) shares gap up - still a buy?  MarketBeat Sat, 20 Sep 2025 15:56:40 GMT
 otsuka receives approval to market nexletol in japan for cholesterol  StreetInsider Fri, 19 Sep 2025 12:03:42 GMT
 otsuka gains approval for nexletol in japan  The Pharma Letter Fri, 19 Sep 2025 09:35:39 GMT
 Esperion Partner Otsuka Receives Regulatory Approval to  GlobeNewswire Fri, 19 Sep 2025 07:00:00 GMT
 esperion stock rises after japan approves cholesterol drug nexletol  Investing.com Fri, 19 Sep 2025 07:00:00 GMT
 esperion’s cholesterol drug nexletol receives approval in japan  Investing.com Fri, 19 Sep 2025 07:00:00 GMT
 espr stock price and chart — nasdaq:espr  TradingView Fri, 19 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 20:43:23  خودرو بانک Tue, 16 Sep 2025 17:16:50 GMT
 esperion therapeutics (nasdaq:espr) shares up 7.1% - what's next?  MarketBeat Tue, 16 Sep 2025 03:22:30 GMT
 esperion therapeutics stock gains momentum on strong fundamentals  AD HOC NEWS Sun, 14 Sep 2025 10:45:04 GMT
 esperion therapeutics (nasdaq:espr) shares up 7.1% - here's why  MarketBeat Sat, 13 Sep 2025 18:57:14 GMT
 esperion therapeutics, inc. $espr holdings raised by invesco ltd.  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 esperion: a mixture of opportunity and risk: why i would hold for now  Seeking Alpha Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 06:44:23  Newser Fri, 05 Sep 2025 11:44:23 GMT
 published on: 2025-09-05 00:43:55  Newser Fri, 05 Sep 2025 05:43:55 GMT
 published on: 2025-09-04 00:22:02  Newser Thu, 04 Sep 2025 05:22:02 GMT
 published on: 2025-09-03 04:01:00  Newser Wed, 03 Sep 2025 09:01:00 GMT
 published on: 2025-09-02 13:26:49  Newser Tue, 02 Sep 2025 18:26:49 GMT
 published on: 2025-09-01 01:32:54  Newser Mon, 01 Sep 2025 06:32:54 GMT
 published on: 2025-08-31 09:47:42  Newser Sun, 31 Aug 2025 14:47:42 GMT
 biotech movers: akebia shares down after pricing stock offering  TheStreet Sat, 30 Aug 2025 18:04:26 GMT
 published on: 2025-08-30 07:46:52  Newser Sat, 30 Aug 2025 12:46:52 GMT
 esperion stock target cut to $4 by jmp securities  MSN Sat, 30 Aug 2025 00:37:30 GMT
 published on: 2025-08-29 12:43:36  Newser Fri, 29 Aug 2025 17:43:36 GMT
 published on: 2025-08-29 11:33:57  Newser Fri, 29 Aug 2025 16:33:57 GMT

Esperion Therapeutics, Inc
(NASDAQ:ESPR) 

ESPR stock logo

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic aci...

Founded: 1998
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends